BRAIDWELL LP - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 12 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
BRAIDWELL LP ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$40,943,996
-4.8%
65,976,0000.0%1.29%
-8.0%
Q2 2023$43,016,352
-15.9%
65,976,0000.0%1.41%
-16.7%
Q1 2023$51,148,346
+3.6%
65,976,0000.0%1.69%
+2.0%
Q4 2022$49,369,84165,976,0001.65%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Opti Capital Management, LP 15,000,000$15,028,0001.61%
Context Capital Management, LLC 13,000$13,039,0001.21%
STEELHEAD PARTNERS LLC 14,000,000$13,941,0000.92%
PenderFund Capital Management Ltd. 3,000,000$3,754,0000.88%
AQR Arbitrage LLC 7,000,000$7,021,0000.20%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 20,000,000$19,960,0000.16%
CSS LLC/IL 2,000,000$1,991,0000.08%
FARALLON CAPITAL MANAGEMENT LLC 10,000,000$10,456,0000.04%
LAZARD ASSET MANAGEMENT LLC 17,500,000$17,552,0000.02%
Daiwa Securities Group Inc. 3,000,000$3,004,0000.02%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders